Identification of the Key LMO2-binding Determinants on Ldb1

This publication has 41 references indexed in Scilit:

• The Role of LMO2 in Development and in T Cell Leukemia After Chromosomal Translocation or Retroviral Insertion
  Molecular Therapy, 2006
• TheLMO2T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development
  Molecular and Cellular Biology, 2003
• LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
  Science, 2003
• The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target
  Oncogene, 2002
• Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
  Cancer Cell, 2002
• The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice
  Proceedings of the National Academy of Sciences, 2000
• The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis
  Proceedings of the National Academy of Sciences, 1998
• The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation
  Proceedings of the National Academy of Sciences, 1997
• Ectopic expression of rhombotin-2 causes selective expansion of CD4-CD8- lymphocytes in the thymus and T-cell tumors in transgenic mice
  Blood, 1995
• The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development
  Cell, 1994